Back

Prevention of VEGF inhibitor-induced toxicity by salt restriction: the SUN-SALT study

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Pharmacology and pharmacotherapy e-posters Cardiovascular Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Associate Professor Jorie Versmissen

Erasmus University Rotterdam, Rotterdam (Netherlands (The))

57 More presentations in this session

Presentation thumbnail
Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials
Doctor J. Borovac (Split, HR)
Abstract Slides
Presentation thumbnail
The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus
Doctor A. KANWAL (Valhalla, US)
Abstract Slides
Presentation thumbnail
Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.
Doctor K. Dzaurova (Moscow, RU)
Abstract Slides
Presentation thumbnail
The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis
Mrs A. Boulmpou (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis
Mrs A. Boulmpou (Nijmegen, NL)
Abstract Slides

Access the full session

Session thumbnail
Pharmacology and pharmacotherapy e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Case 2: a patient with hypertension during cancer therapy
2 September 2024
thumbnail
Congress Presentation
Effect of high-salt diet and its cancel on renovascular hypertension in female Wistar rats
29 June 2021
thumbnail
Congress Presentation
Effect of intravitreal anti-vascular endothelial growth factor therapy on aortic stiffness and serum interleukin-6 levels in hypertensive patients with age-related macular degeneration
2 September 2019
thumbnail
Congress Presentation
Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources